This P/L chart will make your eyes pop (ad) |
Today I want to show you how our research shows you could've grown a $25,000 account into $109,616.12 within the last TWO months.
You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists…
It's a revolutionary software system that tracks the moves of institutional investors…. in real time…
Go here to watch the most recent trading workshop video at no charge. |
|
Trump Stopping Central Bank Digital Currency – Assassination Attempt! (ad) |
|
- COO Javier Olivan sold 413 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $536.92, for a total value of $221,747.96. Following the completion of the sale, the chief operating officer now owns 14,424 shares of the company's stock, valued at $7,744,534.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
- (8/28) Meta Platforms, Inc. (NASDAQ:META) COO Sells $221,747.96 in Stock (insidertrades.com)
- (8/28) Meta Platforms strikes geothermal energy deal with Sage Geosystems to power US data centers (msn.com)
- (8/27) Meta has abandoned efforts to make custom chips for its upcoming AR glasses (finance.yahoo.com)
- (8/27) Meta Platforms, Inc. (NASDAQ:META) Holdings Trimmed by AustralianSuper Pty Ltd (marketbeat.com)
- (8/27) FLASHBACK: Top Harris campaign aide was key voice in WH push to remove COVID info from tech platforms (msn.com)
- (8/27) Mark Zuckerberg Alleges Biden Administration Pressured Meta To Censor Content During Covid (markets.businessinsider.com)
- (8/27) Loop Capital Markets Remains a Buy on Meta Platforms (META) (markets.businessinsider.com)
- (8/27) Meta to Shut Down Platform for Third-Party Augmented Reality Effects (pymnts.com)
- (8/27) Meta to shut augmented reality studio used by third-party creators (gazette.com)
- (8/27) Zuckerberg says White House 'pressured' Meta to pull covid posts (spokesman.com)
- AeroVironment (NASDAQ:AVAV) was upgraded by analysts at Alembic Global Advisors from a "neutral" rating to an "overweight" rating. They now have a $216.00 price target on the stock. This represents a 7.5% upside from the current price of $200.88.
- AeroVironment (NASDAQ:AVAV) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $220.00 price target on the stock, up previously from $161.00. This represents a 9.5% upside from the current price of $200.88.
- Concentrix (NASDAQ:CNXC) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $85.00 price target on the stock, up previously from $65.00. This represents a 13.6% upside from the current price of $74.82.
- Delek Logistics Partners (NYSE:DKL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $44.00. This represents a 15.0% upside from the current price of $39.12.
- EastGroup Properties (NYSE:EGP) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $214.00 price target on the stock, up previously from $179.00. This represents a 14.9% upside from the current price of $186.20.
- Illumina (NASDAQ:ILMN) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock. This represents a 14.6% upside from the current price of $130.87.
- Kite Realty Group Trust (NYSE:KRG) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $23.00. This represents a 0.2% downside from the current price of $26.06.
- Moderna (NASDAQ:MRNA) was upgraded by analysts at HSBC Holdings plc from a "reduce" rating to a "hold" rating. They now have a $82.00 price target on the stock. This represents a 4.3% upside from the current price of $78.59.
- ArcelorMittal (NYSE:MT) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $31.00 price target on the stock, up previously from $29.00. This represents a 32.4% upside from the current price of $23.41.
- Grupo Aeroportuario del PacÃfico (NYSE:PAC) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.The current price is $174.05.
- Phillips Edison & Company, Inc. (NASDAQ:PECO) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $37.00 price target on the stock, up previously from $34.00. This represents a 0.1% upside from the current price of $36.95.
- View today's most recent analysts' upgrades at MarketBeat.com
Bitcoin has surged past $70,000. Are you prepared for what's next? Our free guide, "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024," is essential for staying ahead in the fast-evolving crypto market. It's crafted for both beginners and seasoned investors. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Click here to download your free report and start leading in the crypto race. |
|
- Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $112.00 price target on the stock, down previously from $123.00. This represents a 36.8% upside from the current price of $81.88.
- Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $117.00 price target on the stock, down previously from $134.00. This represents a 42.9% upside from the current price of $81.88.
- Cinemark (NYSE:CNK) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $27.71.
- Gannett (NYSE:GCI) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $5.10 price target on the stock. This represents a 6.8% downside from the current price of $5.47.
- Lifecore Biomedical (NASDAQ:LFCR) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $3.93.
- Semtech (NASDAQ:SMTC) was downgraded by analysts at Summit Insights from a "buy" rating to a "hold" rating.The current price is $39.43.
- Terreno Realty (NYSE:TRNO) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $75.00 price target on the stock, up previously from $71.00. This represents a 8.3% upside from the current price of $69.24.
- TransUnion (NYSE:TRU) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $94.98.
- View today's most recent analysts' downgrades at MarketBeat.com
Goodbye to Cash: The Era of the Digital Dollar Revolution Begins (ad) |
Something critical just happened... In June the BRICS nations — Brazil, Russia, India, China, and South Africa — met. They weren't just chatting about trade. No, they were plotting to dismantle the dominance of the U.S. dollar in global trade. A new trade system, free from the dollar. What does that spell for the dollar's future? Trouble.
Download Your FREE Guide Now >> |
|
- Arcutis Biotherapeutics (NASDAQ:ARQT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock. This represents a 41.0% upside from the current price of $10.64.
- Byrna Technologies (NASDAQ:BYRN) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $14.00 price target on the stock. This represents a 24.7% upside from the current price of $11.23.
- Cognizant Technology Solutions (NASDAQ:CTSH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $90.00 price target on the stock. This represents a 15.9% upside from the current price of $77.66.
- Diversified Energy (NYSE:DEC) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 45.0% upside from the current price of $12.41.
- Quest Diagnostics (NYSE:DGX) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $165.00 price target on the stock. This represents a 6.7% upside from the current price of $154.69.
- EHang (NASDAQ:EH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $22.00 price target on the stock. This represents a 56.9% upside from the current price of $14.02.
- enGene (NASDAQ:ENGN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 338.6% upside from the current price of $6.84.
- EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock. This represents a 67.4% upside from the current price of $8.96.
- Fiserv (NYSE:FI) is now covered by analysts at BTIG Research. They set a "buy" rating and a $200.00 price target on the stock. This represents a 16.3% upside from the current price of $171.97.
- GCT Semiconductor (NYSE:GCTS) is now covered by analysts at B. Riley. They set a "buy" rating and a $8.00 price target on the stock. This represents a 168.5% upside from the current price of $2.98.
- (IHS) (NYSE:IHS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock. This represents a 44.5% upside from the current price of $3.46.
- NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $36.00 price target on the stock. This represents a 115.4% upside from the current price of $16.71.
- Nanobiotix (NASDAQ:NBTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock. This represents a 110.5% upside from the current price of $5.70.
- Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $63.00 price target on the stock. This represents a 42.5% upside from the current price of $44.21.
- SAB Biotherapeutics (NASDAQ:SABS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 318.1% upside from the current price of $2.87.
- Vista Energy (NYSE:VIST) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $70.00 price target on the stock. This represents a 37.5% upside from the current price of $50.90.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Kamala Harris' Woke Politics Could Lead to 50% Stock Collapse |
No comments:
Post a Comment